Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell sequencing reveals heterogeneity between pancreatic adenosquamous carcinoma and pancreatic ductal adenocarcinoma with prognostic value. | Front Immunol | 2022 | 36052088 | PubTator, text mining | PubMed |
| Expression characteristics of the yes-associated protein in breast cancer: A meta-analysis. | Medicine (Baltimore) | 2022 | 36042678 | PubTator, text mining | PubMed |
| Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop. | Cell Death Dis | 2022 | 36042208 | PubTator, text mining | PubMed |
| WhichTF is functionally important in your open chromatin data? | PLoS Comput Biol | 2022 | 36040971 | PubTator, text mining | PubMed |
| Posttranslational control of lipogenesis in the tumor microenvironment. | J Hematol Oncol | 2022 | 36038892 | PubTator, text mining | PubMed |
| Long non-coding RNA LINC00152 in cancer: Roles, mechanisms, and chemotherapy and radiotherapy resistance. | Front Oncol | 2022 | 36033524 | PubTator, text mining | PubMed |
| Gene expression analysis reveals a 5-gene signature for progression-free survival in prostate cancer. | Front Oncol | 2022 | 36033512 | PubTator, text mining | PubMed |
| A novel regulated network mediated by downregulation HIF1A-AS2 lncRNA impairs placental angiogenesis by promoting ANGPTL4 expression in preeclampsia. | Front Cell Dev Biol | 2022 | 36016656 | PubTator, text mining | PubMed |
| LINC00665 affects the malignant biological behavior of ovarian cancer via the miR-148b-3p/KLF5. | Syst Biol Reprod Med | 2022 | 36016468 | PubTator, text mining | PubMed |
| Antiproliferative Copper(II) Complexes Bearing Mixed Chelating Ligands: Structural Characterization, ROS Scavenging, In Silico Studies, and Anti-Melanoma Activity. | Pharmaceutics | 2022 | 36015318 | PubTator, text mining | PubMed |
| Regulation of Embryonic Stem Cell Self-Renewal. | Life (Basel) | 2022 | 36013330 | PubTator, text mining | PubMed |
| KLF5 governs sphingolipid metabolism and barrier function of the skin. | Genes Dev | 2022 | 36008138 | PubTator, text mining | PubMed |
| Kruppel Like Factor 5 Enhances High Glucose-Induced Renal Tubular Epithelial Cell Transdifferentiation in Diabetic Nephropathy. | Crit Rev Eukaryot Gene Expr | 2022 | 36004694 | PubTator, text mining | PubMed |
| Integrated analysis of anti-tumor roles of BAP1 in osteosarcoma. | Front Oncol | 2022 | 36003792 | PubTator, text mining | PubMed |
| Krüppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency. | Cell Rep | 2022 | 36001968 | PubTator, text mining | PubMed |
| Integrated single-cell RNA-seq and DNA methylation reveal the effects of air pollution in patients with recurrent spontaneous abortion. | Clin Epigenetics | 2022 | 35999615 | PubTator, text mining | PubMed |
| Single cell full-length transcriptome of human subcutaneous adipose tissue reveals unique and heterogeneous cell populations. | iScience | 2022 | 35992069 | PubTator, text mining | PubMed |
| Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases. | Mol Ther Nucleic Acids | 2022 | 35991314 | PubTator, text mining | PubMed |
| Single-Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2022 | 35986392 | PubTator, text mining | PubMed |
| Thymocyte regulatory variant alters transcription factor binding and protects from type 1 diabetes in infants. | Sci Rep | 2022 | 35986039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=43